Study title:
AN 10233642 Medline 20070101.
TI Diffuse cutaneous mastocytosis responding to cyproheptadine.
SO Clinical and experimental dermatology, {Clin-Exp-Dermatol}, Jan 1999, vol. 24, no. 1, p. 16-8, ISSN: 0307-6938.
AU Enomoto-U, Kusakabe-H, Matsumura-T, Kuno-T, Tamai-H, Kiyokane-K. IN Department of Dermatology, Osaka Medical College, Osaka, Japan. YR 1999.AN 10233642 Medline 20070101.
TI Diffuse cutaneous mastocytosis responding to cyproheptadine.
SO Clinical and experimental dermatology, {Clin-Exp-Dermatol}, Jan 1999, vol. 24, no. 1, p. 16-8, ISSN: 0307-6938.
AU Enomoto-U, Kusakabe-H, Matsumura-T, Kuno-T, Tamai-H, Kiyokane-K. IN Department of Dermatology, Osaka Medical College, Osaka, Japan. YR 1999.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYPROHEPTADINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|